Diagnostics
20 US-listed companies in this industry.
Companies
20 listed
| Company | Revenue | Net income | Margin | ROE | Revenue 5y | Years |
|---|---|---|---|---|---|---|
| IDXXIDEXX LABORATORIES INC | $4.30 B | $1.06 B | 24.6% | 66.2% | +9.7% | 18 |
| QDELQuidelOrtho Corp | $2.73 B | -$1.13 B | -41.5% | -46.1% | +10.4% | 6 |
| LNTHLantheus Holdings, Inc. | $1.54 B | $233.6 M | 15.2% | 21.4% | +35.3% | 13 |
| NEOGNEOGEN CORP | $870.4 M | -$7.9 M | -0.9% | -0.4% | +13.2% | 17 |
| NTLAIntellia Therapeutics, Inc. | $67.7 M | -$412.7 M | -609.9% | -53.5% | +3.1% | 10 |
| CLDXCelldex Therapeutics, Inc. | $1.5 M | -$258.8 M | · | -40.6% | -26.9% | 17 |
| MYGNMYRIAD GENETICS INC | $824.5 M | -$365.9 M | -44.4% | -68.5% | +8.2% | 18 |
| NYMXFNYMOX PHARMACEUTICAL CORP | · | -$4.5 M | · | · | · | 9 |
| TRIBTRINITY BIOTECH PLC | $61.6 M | -$31.8 M | -50.7% | · | -7.4% | 10 |
| ICCCIMMUCELL CORP | $27.6 M | -$1.0 M | -3.8% | -3.8% | +12.5% | 17 |
| AWHLAspira Women's Health Inc. | $9.2 M | -$12.8 M | -138.7% | · | +14.7% | 16 |
| NNNNAnbio Biotechnology | $8.6 M | $6.4 M | 74.1% | 27.0% | · | 4 |
| BMRABIOMERICA INC | $4.5 M | -$3.8 M | -84.8% | -112.1% | -9.2% | 16 |
| IMDXInsight Molecular Diagnostics Inc. | $4.1 M | -$50.2 M | -1238.5% | · | · | 6 |
| VNRXVOLITIONRX LTD | $1.7 M | -$23.4 M | -1360.6% | · | +164.1% | 9 |
| VRAXVirax Biolabs Group Ltd | $6,331 | -$6.1 M | · | -109.6% | · | 5 |
| BZYRBURZYNSKI RESEARCH INSTITUTE INC | $0 | -$1.4 M | · | · | · | 13 |
| QCLSQ/C TECHNOLOGIES, INC. | · | -$11.6 M | · | -73.7% | · | 7 |
| TKNOAlpha Teknova, Inc. | $40.5 M | -$17.3 M | -42.6% | -22.8% | +5.3% | 6 |
| CDIOCardio Diagnostics Holdings, Inc. | $14,825 | -$6.5 M | · | -78.6% | · | 5 |
"·" marks a figure not available in our data.